Behcet's Disease with Uveitis in Taiwan

被引:15
|
作者
Chung, Yu-Mei [1 ,2 ]
Lin, Ying-Cheng [4 ]
Tsai, Chia-Chen [5 ]
Huang, De-Feng [3 ]
机构
[1] Taipei Vet Gen Hosp, Dept Ophthalmol, Uveitis Serv, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Dept Ophthalmol, Uveitis Serv, Sch Med, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Dept Med, Div Allergy Immunol & Rheumatol, Sch Med, Taipei 112, Taiwan
[4] Taipei City Hosp Yang Ming Branch, Dept Ophthalmol, Taipei, Taiwan
[5] Cheng Hsin Gen Hosp, Dept Ophthalmol, Taipei, Taiwan
关键词
Behcet's disease; Chinese; Taiwan; uveitis;
D O I
10.1016/S1726-4901(08)70159-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Behcet's disease is a multisystemic inflammatory disease which may lead to blindness. The purpose of this study was to describe and compare the clinical features and visual outcome of Behcet's uveitis in Taiwan. Methods: The medical charts of 227 consecutive patients (414 eyes) with Behcet's uveitis who were seen in the Uveitis Clinic of Taipei Veterans General Hospital were reviewed: 96 patients (group A) between 1984 and 1993 and 131 (group B) between 1994 and 2003. Results: The male-to-female ratio was 1.6. The mean age at the time of uveitis onset was 30.8 years. Males were most affected in the 3(rd) and 4(th) decades and females in the 2(nd) to 5(th) decades. There were more skin and gastrointestinal lesions in males, and less skin and genital lesions in group B. HLA-B51 antigen was found in 35.7% of patients. Treatment with cyclosporin, azathioprine and methotrexate was more frequent in group B. Uveitis occurred bilaterally in 83.9% of patients. At the first visit, potential visual acuity (VA) was 0.1 or less in 24.7% of eyes in males and 11.4% in females. The mean time from presentation to loss of useful vision (> 0.1) was 51 months in 19.1% of eyes. Kaplan-Meier survival analysis estimated the risks of losing useful vision at 5, 10 and 15 years as being 22.6%, 43.0% and 58.5%, respectively. VA at the first and last visits were better and VA deterioration slower in group B. Conclusion: Visual outcome is poorer in males than in females and has improved in the recent decade, but still a significant proportion of patients lose their vision quickly. The number of new patients has not decreased. [J Chin Med Assoc 2008; 71(10):509-516]
引用
收藏
页码:509 / 516
页数:8
相关论文
共 50 条
  • [1] Behcet's Disease Uveitis
    Joubert, Morgane
    Desbois, Anne-Claire
    Domont, Fanny
    Ghembaza, Amine
    Le Joncour, Alexandre
    Mirouse, Adrien
    Maalouf, Georgina
    Leclercq, Mathilde
    Touhami, Sarah
    Cacoub, Patrice
    Bodaghi, Bahram
    Saadoun, David
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [2] Behcet's disease uveitis
    Joubert, M.
    Desbois, A. -C.
    Domont, F.
    Ghembaza, A.
    Lejoncour, A.
    Mirouse, A.
    Maalouf, G.
    Leclercq, M.
    Touhami, S.
    Cacoub, P.
    Bodaghi, B.
    Saadoun, D.
    [J]. REVUE DE MEDECINE INTERNE, 2023, 44 (10): : 546 - 554
  • [3] Uveitis associated with Behcet's disease
    Saadoun, D.
    Bodaghi, B.
    [J]. REVUE DE MEDECINE INTERNE, 2022, 43 : A277 - A286
  • [4] Azathioprine in Severe Uveitis of Behcet's Disease
    Saadoun, D.
    Wechsler, B.
    Terrada, C.
    Hajage, D.
    Huong, D. Le Thi
    Resche-Rigon, M.
    Cassoux, N.
    Le Hoang, P.
    Amoura, Z.
    Bodaghi, B.
    Cacoub, P.
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (12) : 1733 - 1738
  • [5] Effect of infliximab on refractory uveitis in Behcet's disease
    Sayarlioglu, M
    Cinal, A
    Topcu, N
    Demirok, A
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (05) : 901 - 902
  • [6] Gender Differences in Behcet's Disease Associated Uveitis
    Ucar-Comlekoglu, Didar
    Fox, Austin
    Sen, H. Nida
    [J]. JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [7] INTERFERON ALPHA FOR TREATMENT OF UVEITIS IN BEHCET'S DISEASE
    Dubey, Rahul
    Wakefield, Dennis
    McCluskey, Peter
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 39 - 39
  • [8] Infliximab in refractory uveitis due to Behcet's disease
    Wechsler, B
    Sablé-Fourtassou, R
    Bodaghi, B
    Huong, DLT
    Cassoux, N
    Badelon, I
    Fain, O
    LeHoang, P
    Piette, JC
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (04) : S14 - S16
  • [9] Plasma homocysteine level and uveitis in Behcet's disease
    Okka, M
    Öztürk, M
    Korkar, MC
    Bavbek, N
    Rasier, Y
    Gunduz, K
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (11): : 931 - 934
  • [10] INFLIXIMAB TREATMENT FOR UVEITIS IN PATIENTS WITH BEHCET'S DISEASE
    Uehara, Takeaki
    Takeno, Mitsuhiro
    Hama, Maasa
    Omura, Kenji
    Suda, Akiko
    Ihata, Atsushi
    Ueda, Atsuhisa
    Ishigatsubo, Yoshiaki
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S123 - S123